APA (7th ed.) Citation

Taipale, H., Solmi, M., Lähteenvuo, M., Tanskanen, A., Correll, C., & Tiihonen, J. (2021). P.0453 Antipsychotic use and risk of breast cancer in women with schizophrenia. European Neuropsychopharmacology, 53, S331. https://doi.org/10.1016/j.euroneuro.2021.10.426

Chicago Style (17th ed.) Citation

Taipale, H., M. Solmi, M. Lähteenvuo, A. Tanskanen, C. Correll, and J. Tiihonen. "P.0453 Antipsychotic Use and Risk of Breast Cancer in Women with Schizophrenia." European Neuropsychopharmacology 53 (2021): S331. https://doi.org/10.1016/j.euroneuro.2021.10.426.

MLA (9th ed.) Citation

Taipale, H., et al. "P.0453 Antipsychotic Use and Risk of Breast Cancer in Women with Schizophrenia." European Neuropsychopharmacology, vol. 53, 2021, p. S331, https://doi.org/10.1016/j.euroneuro.2021.10.426.